Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
Michalis Liontos, Maria Kaparelou, Emmanouil Karofylakis and 5 more
Gynecologic Oncology Reports · 2020
doi:10.1016/j.gore.2020.100615 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
•Chemotherapy resumption after convalescence from COVID-19 is safe and feasible.•No guidelines exist for resumption of chemotherapy in patients with COVID-19.•Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.
Abstract licence: CC BY-NC-ND
References10
- 8.
9 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.